These data illustrate how cost and outcome studies are at the forefront of the research that is measuring and defining the role of coronary CTA. The coronary CTA is so innovative in the domain of acute chest pain, there is a paucity of published work that looks at the cost; instead, the majority of the literature examines outcomes and is produced primarily by cardiology.